Clinical Study
Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow
Figure 5
Plasma Trimetylamine-oxide (TMAO), L-carnitine, and betaine levels in the NCF group and SCF group. (a) Plasma TMAO concentration in patients with NCF and SCF, (b) plasma betaine level in patients with NCF and SCF, and (c) plasma L-carnitine level in patients with NCF and SCF. Data were expressed as mean ± standard error of the mean.
(a) |
(b) |
(c) |